Faculty

Maria Alice V. Willrich, Ph.D.

Clinical Studies

HLA DQ Alleles Associated with Increased Risk for Developing Anti-drug Antibodies to Infliximab or Adalimumab Rochester, Minn.
The purpose of this study is to develop a laboratory test to determine if an individual is at risk of developing antibodies to one of these two monoclonal therapies based on their HLA-DQ genotype.

Mutational Analysis of Alternative Pathway Complement Regulatory Proteins Rochester, Minn.
The purpose of this study is to develop and validate full gene-sequencing assays or known mutation sequencing assays for the evaluation of patients with suspected alternative pathway complement defects.